Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Docobo

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|November 18, 2008
Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipientsL Barrera-Pulido, I Aguilera-García, F Docobo-Pérez, et al.
International Journal of Antimicrobial Agents|January 15, 2023
RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coliS Diaz-Diaz, Pilar Yerbes, E Recacha, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 12, 2010
Local imipenem activity against Pseudomonas aeruginosa decreases in vivo in the presence of siliconized latexC Pichardo, M C Conejo, F Docobo-Pérez, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2017
Molecular insights into fosfomycin resistance in Escherichia coliM Ballestero-Téllez, F Docobo-Pérez, I Portillo-Calderón, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2021
Activity of fosfomycin and amikacin against fosfomycin-heteroresistant <i>Escherichia coli</i> strains in a <i>hollow-fiber</i> infection modelI Portillo-Calderón, M Ortiz-Padilla, B de Gregorio-Iaria, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 12, 2011
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumanniiR López-Rojas, F Docobo-Pérez, M E Pachón-Ibáñez, et al.
Cirugia Espanola|November 15, 2011
[Training of residents in abdominal wall surgery in Spain]J M Miguelena Bobadilla, D Morales García, X Serra Aracil, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2020
Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coliJ Machuca, E Recacha, B Gallego-Mesa, et al.
The Journal of Antimicrobial Chemotherapy|March 16, 2013
Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83LeuJ Domínguez-Herrera, C Velasco, F Docobo-Pérez, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonatesV Ramos-Martín, A Johnson, J Livermore, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|November 18, 2008
Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipientsL Barrera-Pulido, I Aguilera-García, F Docobo-Pérez, et al.
International Journal of Antimicrobial Agents|January 15, 2023
RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coliS Diaz-Diaz, Pilar Yerbes, E Recacha, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 12, 2010
Local imipenem activity against Pseudomonas aeruginosa decreases in vivo in the presence of siliconized latexC Pichardo, M C Conejo, F Docobo-Pérez, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2017
Molecular insights into fosfomycin resistance in Escherichia coliM Ballestero-Téllez, F Docobo-Pérez, I Portillo-Calderón, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2021
Activity of fosfomycin and amikacin against fosfomycin-heteroresistant <i>Escherichia coli</i> strains in a <i>hollow-fiber</i> infection modelI Portillo-Calderón, M Ortiz-Padilla, B de Gregorio-Iaria, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 12, 2011
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumanniiR López-Rojas, F Docobo-Pérez, M E Pachón-Ibáñez, et al.
Cirugia Espanola|November 15, 2011
[Training of residents in abdominal wall surgery in Spain]J M Miguelena Bobadilla, D Morales García, X Serra Aracil, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2020
Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coliJ Machuca, E Recacha, B Gallego-Mesa, et al.
The Journal of Antimicrobial Chemotherapy|March 16, 2013
Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83LeuJ Domínguez-Herrera, C Velasco, F Docobo-Pérez, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonatesV Ramos-Martín, A Johnson, J Livermore, et al.
Pageof 7